Tumor safety of biologic agents and targeted therapies in immune-mediated inflammatory arthritides - Top-Institutions - MDSpire

Tumor safety of biologic agents and targeted therapies in immune-mediated inflammatory arthritides

By
Sheng-Guang Li
Yadan Zou
Ji Li
Lina Zhang
Jing Zhang
Ting Long
Ruohan Yu
Yanfeng Zhang
June 4, 2026
0 min

Frontiers In Immunology

Share

Top Institutions in Rheumatology

Brief introduction explaining scope and methodology.

#1

Brigham and Women's Hospital

Boston, Massachusetts
Key Differentiators
- Rheumatology
- Pharmacoepidemiology
#2

The Johns Hopkins Hospital

Baltimore, Maryland
Key Differentiators
- Rheumatology
- Translational Research
#3

NYU Langone Health

New York, New York
Key Differentiators
- Rheumatology
- Clinical Trials
#4

University of California San Diego

La Jolla, California
Key Differentiators
- Rheumatology
- Immunology
#5

Ochsner Health System

New Orleans, Louisiana
Key Differentiators
- Rheumatology
- Patient Care

Original Source(s)

Frontiers In Immunology

Tumor safety of biologic agents and targeted therapies in immune-mediated inflammatory arthritides

by Sheng-Guang Li, Yadan Zou, Ji Li, Lina Zhang, Jing Zhang, Ting Long, Ruohan Yu, Yanfeng Zhang
June 4, 2026

Related Content

Conexiant

AAO Updates HCQ Retinopathy Guidance

Updated recommendations emphasize dosing limits and screening for toxicity risk.

by Andrea Surnit
April 23, 2026
3 min

Conexiant

AI Scribes Lag Clinicians on Note Quality

A VHA study across 11 vendors finds AI-generated primary care notes score lower than clinician-written notes, with the largest deficits in thoroughness, organization, and usefulness

by Kerri Miller
April 17, 2026
6 min

Frontiers In Immunology

Case Study: Pediatric Dermatomyositis Associated with Acute Myeloid Leukemia - Successful Long-Term Remission Following Hematopoietic Stem Cell Transplantation

by Pan Fu, Kai Chen, Qing Liu, Bing Zou, Zhen Wang, Dan Wang, Hui Jiang, Na Zhang, Jingbo Shao
April 23, 2026